General Information of Drug Inactive Ingredient (DIG) (ID: E00366)

DIG Name
Tricaprin
Synonyms
Tricaprin; Tridecanoin; 621-71-6; Glycerol tricaprate; Glycerol tridecanoate; Glyceryl tridecanoate; Decanoin, tri-; Caprin; Tricapric glyceride; Glycerol tricaprin; 1,2,3-Tridecanoylglycerol; Capric acid triglyceride; Glyceryl tricaprate; Dynasan 110; tri-n-Caprin; Decanoic acid, 1,2,3-propanetriyl ester; 2,3-di(decanoyloxy)propyl decanoate; propane-1,2,3-triyl tris(decanoate); Propane-1,2,3-triyl tridecanoate; UNII-O1PB8EU98M; Capric triglyceride; 1,2,3-Propanol tridecanoate; Glycerin tridecanoate; NSC 147475; tridecanoin C10:0; O1PB8EU98M; 1,2,3-tricaprinoyl-glycerol; 1,2,3-tridecanoyl-sn-glycerol; 1,2,3-tridecanoyl-sn-sn-glycerol; 2,3-Bis(decanoyloxy)propyl decanoate; Decanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester; ASTM D6584 Tricaprin Solution, Internal Standard #2; TG(10:0/10:0/10:0); Glycerol tris(decanoate); EINECS 210-702-0; 1,2,3-Tricaprinoylglycerol; BRN 1717683; tri-Decanoin; AI3-36968; 1,2,3-Tridecanoyl-rac-glycerol; Glycerol tridecanoic acid; Glyceryl tridecanoic acid; Decanoin, tri- (8CI); bmse000566; 4-02-00-01047 (Beilstein Handbook Reference); GLYCEROL TRI-N-CAPRATE; SCHEMBL126224; T7517_SIGMA; Tridecanoin;Glycerol tricaprate; 1,2, 3-propanetriyl-Decanoate; DTXSID1042651; CHEBI:77388; BCP31609; C33H62O6; HY-N6660; 1,2, 3-propanetriyl-Decanoic acid; 6949AF; ANW-42090; LMGL03012617; MFCD00036239; NSC147475; ZINC32786165; Decanoic acid,2,3-propanetriyl ester; Glyceryl tridecanoate, >=99% (GC); AKOS015899809; CCG-270027; MCULE-5558247364; NSC-147475; Tricaprin 8000 microg/mL in Pyridine; 2,3-Bis(decanoyloxy)propyl decanoate #; 2,3-bis(decanoyloxy)propyl decanoic acid; 3,6,9,12,15,18,21,24,27,30-Decaoxadotriacontan-1-ol,32-(4-(1,1,3,- 3-tetramethylbutyl)phenoxy)-; CS-0083196; FT-0704752; S5731; 2,3-bis(decanoyloxy)propyl decanoate (ACD/Name 4.0); Q27146923; TG 10:0/10:0/10:0; Tricaprin, certified reference material, TraceCERT(R); Tricaprin, European Pharmacopoeia (EP) Reference Standard; UNII-43AGM4PHPI component LADGBHLMCUINGV-UHFFFAOYSA-N; UNII-C9H2L21V7U component LADGBHLMCUINGV-UHFFFAOYSA-N; UNII-FJ1H6M2JG9 component LADGBHLMCUINGV-UHFFFAOYSA-N; UNII-J4BY50FL78 component LADGBHLMCUINGV-UHFFFAOYSA-N; UNII-ZF29F7IK5I component LADGBHLMCUINGV-UHFFFAOYSA-N; UNII-U73D397055 component LADGBHLMCUINGV-UHFFFAOYSA-N
DIG Function
Emollient
Formula
C33H62O6
Canonical SMILES
CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)OC(=O)CCCCCCCCC
InChI
1S/C33H62O6/c1-4-7-10-13-16-19-22-25-31(34)37-28-30(39-33(36)27-24-21-18-15-12-9-6-3)29-38-32(35)26-23-20-17-14-11-8-5-2/h30H,4-29H2,1-3H3
InChIKey
LADGBHLMCUINGV-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 554.8 Topological Polar Surface Area 78.9
XlogP 12.2 Complexity 543
Heavy Atom Count 39 Rotatable Bond Count 32
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 6

Full List of Drug(s) Co-administrated with This DIG

1 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Lamotrigine DM8SXYG Bipolar disorder [6A60] Lamotrigine 250 mg tablet F11222
------------------